Healthcare
Live Price
Offline$0.00002
+0.00% today
1Y Change
+100.00%
Window
Jun 23, 2025 → Jun 11, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 11, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Verde Science, Inc. (VRCI) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 100.0% across the available one-year price window (Jun 23, 2025 → Jun 11, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -175.7%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -175.7%, free cash flow -11.7% with operating margin 0.0% and ROIC 333.9%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines VRCI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VRCI
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VRCI Max Drawdown
-93.33%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VRCI and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$177.4K
+17.3% YoY
FY Net Income
-$597.2K
-739.2% YoY
Free Cash Flow
-$384.8K
-607.3% YoY
Revenue Growth
+0.0%
EPS Growth
-175.7%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 228K | 151K | 177K |
| Gross Profit | 0 | 0 | -7K | -117K | -111K |
| Operating Income | -2M | -924K | -2M | -219K | -376K |
| EBITDA | -2M | -924K | -2M | -367K | -176K |
| Net Income | -3M | -798K | -2M | -71K | -597K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|
| Cash & Equivalents | 128 | 203 | 234K | 233K | 2K |
| Total Assets | 128 | 203 | 256K | 233K | 6K |
| Total Liabilities | 795K | 508K | 493K | 528K | 304K |
| Shareholder Equity | -795K | -508K | -237K | -295K | -299K |
| Total Debt | 227K | 252K | 0 | 7K | 5K |
| Net Debt | 227K | 252K | -234K | -226K | 3K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
385K
-607.3% YoY
Capital Expenditures
0
Free Cash Flow
385K
-607.3% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
401.3%
Debt / Equity
-0.29x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.